Tumor Necrosis Factor Gene Variation Predicts Hippocampus Volume in Healthy Individuals

[1]  Janet B W Williams,et al.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[2]  N. Skokauskas,et al.  Reduced expression of glucocorticoid-inducible genes GILZ and SGK-1: high IL-6 levels are associated with reduced hippocampal volumes in major depressive disorder , 2012, Translational Psychiatry.

[3]  Walter Heindel,et al.  Limbic Scars: Long-Term Consequences of Childhood Maltreatment Revealed by Functional and Structural Magnetic Resonance Imaging , 2012, Biological Psychiatry.

[4]  E. Costello,et al.  Cumulative Depression Episodes Predict Later C-Reactive Protein Levels: A Prospective Analysis , 2012, Biological Psychiatry.

[5]  Peter McGuffin,et al.  Hippocampal atrophy in first episode depression: a meta-analysis of magnetic resonance imaging studies. , 2011, Journal of affective disorders.

[6]  Menno P. Witter,et al.  A pathophysiological framework of hippocampal dysfunction in ageing and disease , 2011, Nature Reviews Neuroscience.

[7]  A. Toga,et al.  No effect of 5HTTLPR or BDNF Val66Met polymorphism on hippocampal morphology in major depression , 2011, Genes, brain, and behavior.

[8]  Z. Huo,et al.  [Association of the polymorphisms in the promoter region of tumor necrosis factor alpha and interleukin 6 genes with schizophrenia]. , 2011, Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics.

[9]  M. Bloch,et al.  The Effect of Antidepressant Medication Treatment on Serum Levels of Inflammatory Cytokines: A Meta-Analysis , 2011, Neuropsychopharmacology.

[10]  A. Simmons,et al.  Structural neuroimaging studies in major depressive disorder. Meta-analysis and comparison with bipolar disorder. , 2011, Archives of general psychiatry.

[11]  B. Baune,et al.  Specifying the Neuropsychology of Affective Disorders: Clinical, Demographic and Neurobiological Factors , 2011, Neuropsychology Review.

[12]  R. Murray,et al.  Stress and inflammation reduce brain-derived neurotrophic factor expression in first-episode psychosis: a pathway to smaller hippocampal volume. , 2011, The Journal of clinical psychiatry.

[13]  P. Greengard,et al.  Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans , 2011, Proceedings of the National Academy of Sciences.

[14]  G. MacQueen,et al.  The hippocampus in major depression: evidence for the convergence of the bench and bedside in psychiatric research? , 2011, Molecular Psychiatry.

[15]  Carlo Caltagirone,et al.  ZNF804A risk allele is associated with relatively intact gray matter volume in patients with schizophrenia , 2011, NeuroImage.

[16]  Inbal Goshen,et al.  Immune modulation of learning, memory, neural plasticity and neurogenesis , 2011, Brain, Behavior, and Immunity.

[17]  Zubin Bhagwagar,et al.  Citalopram reduces endotoxin-induced fatigue , 2011, Brain, Behavior, and Immunity.

[18]  M. Falkenstein,et al.  Double dissociated effects of the functional TNF-α -308G/A polymorphism on processes of cognitive control , 2011, Neuropsychologia.

[19]  Bryce Vissel,et al.  The roles of TNF in brain dysfunction and disease. , 2010, Pharmacology & therapeutics.

[20]  M. Heil,et al.  Associations between the tumor necrosis factor alpha gene (-308G→A) and event-related potential indices of attention and mental rotation , 2010, Neuroscience.

[21]  M. Falkenstein,et al.  Variations in the TNF-α gene (TNF-α -308G→A) affect attention and action selection mechanisms in a dissociated fashion. , 2010, Journal of neurophysiology.

[22]  M. Megna,et al.  Cytokine polymorphisms and Alzheimer disease: possible associations , 2010, Neurological Sciences.

[23]  Martin Wiesmann,et al.  Functional Connectivity Bias of the Orbitofrontal Cortex in Drug-Free Patients with Major Depression , 2010, Biological Psychiatry.

[24]  Arthur W. Toga,et al.  Defining the human hippocampus in cerebral magnetic resonance images—An overview of current segmentation protocols , 2009, NeuroImage.

[25]  B. Baune,et al.  The effects of TNF deficiency on age-related cognitive performance , 2009, Psychoneuroendocrinology.

[26]  Charles L. Raison,et al.  Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression , 2009, Biological Psychiatry.

[27]  C. Montag,et al.  The BDNF Val66Met polymorphism impacts parahippocampal and amygdala volume in healthy humans: incremental support for a genetic risk factor for depression , 2009, Psychological Medicine.

[28]  Marie Chupin,et al.  Can voxel based morphometry, manual segmentation and automated segmentation equally detect hippocampal volume differences in acute depression? , 2009, NeuroImage.

[29]  B. Baune,et al.  Evidence for a cytokine model of cognitive function , 2009, Neuroscience & Biobehavioral Reviews.

[30]  J. Sinacore,et al.  Pro-inflammatory biomakers in depression: Treatment with venlafaxine , 2009, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[31]  V. Arolt,et al.  Cognitive dysfunction in mice deficient for TNF‐ and its receptors , 2008, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[32]  Sander Greenland,et al.  Case–Control Studies , 2008 .

[33]  P. Magistretti,et al.  Modulation of astrocytic metabolic phenotype by proinflammatory cytokines , 2008, Glia.

[34]  J. Volpe,et al.  Tumor Necrosis Factor α Mediates Lipopolysaccharide-Induced Microglial Toxicity to Developing Oligodendrocytes When Astrocytes Are Present , 2008, The Journal of Neuroscience.

[35]  S. Rauch,et al.  Evidence for Acquired Pregenual Anterior Cingulate Gray Matter Loss from a Twin Study of Combat-Related Posttraumatic Stress Disorder , 2008, Biological Psychiatry.

[36]  Bernhard T. Baune,et al.  Association between genetic variants of IL-1β, IL-6 and TNF-α cytokines and cognitive performance in the elderly general population of the MEMO-study , 2008, Psychoneuroendocrinology.

[37]  Sébastien Tilleux,et al.  Neuroinflammation and regulation of glial glutamate uptake in neurological disorders , 2007, Journal of neuroscience research.

[38]  Hans-Jürgen Möller,et al.  Association of the brain-derived neurotrophic factor Val66Met polymorphism with reduced hippocampal volumes in major depression. , 2007, Archives of general psychiatry.

[39]  J. O'Callaghan,et al.  Divergent Roles for Tumor Necrosis Factor-α in the Brain , 2007, Journal of Neuroimmune Pharmacology.

[40]  D. Peterson,et al.  Acute Psychosocial Stress Reduces Cell Survival in Adult Hippocampal Neurogenesis without Altering Proliferation , 2007, The Journal of Neuroscience.

[41]  R. Duman,et al.  TNFα Signaling in Depression and Anxiety: Behavioral Consequences of Individual Receptor Targeting , 2006, Biological Psychiatry.

[42]  Pui-Yan Kwok,et al.  Tumor Necrosis Factor-&agr;–238G>A Promoter Polymorphism Is Associated With Increased Risk of New Hemorrhage in the Natural Course of Patients With Brain Arteriovenous Malformations , 2006 .

[43]  P. Kubes,et al.  TNF‐α–secreting monocytes are recruited into the brain of cholestatic mice , 2006 .

[44]  S. Rojas,et al.  Differential role of tumor necrosis factor receptors in mouse brain inflammatory responses in cryolesion brain injury , 2005, Journal of neuroscience research.

[45]  K. Amunts,et al.  Cytoarchitectonic mapping of the human amygdala, hippocampal region and entorhinal cortex: intersubject variability and probability maps , 2005, Anatomy and Embryology.

[46]  M. Pickering,et al.  Actions of TNF‐α on glutamatergic synaptic transmission in the central nervous system , 2005 .

[47]  Simon B. Eickhoff,et al.  A new SPM toolbox for combining probabilistic cytoarchitectonic maps and functional imaging data , 2005, NeuroImage.

[48]  R. Malenka,et al.  Differential Regulation of AMPA Receptor and GABA Receptor Trafficking by Tumor Necrosis Factor-α , 2005, The Journal of Neuroscience.

[49]  Philip B. Ward,et al.  Reduced hippocampal volumes and memory loss in patients with early- and late-onset depression , 2005, British Journal of Psychiatry.

[50]  F. Crews,et al.  TNFα potentiates glutamate neurotoxicity by inhibiting glutamate uptake in organotypic brain slice cultures: neuroprotection by NFκB inhibition , 2005, Brain Research.

[51]  P. Moynagh,et al.  Dissection of tumor-necrosis factor-α inhibition of long-term potentiation (LTP) reveals a p38 mitogen-activated protein kinase-dependent mechanism which maps to early—but not late—phase LTP , 2004, Neuroscience.

[52]  B. Ravnkilde,et al.  Hippocampal volume and depression: a meta-analysis of MRI studies. , 2004, The American journal of psychiatry.

[53]  Michael Marriott,et al.  Lower hippocampal volume in patients suffering from depression: a meta-analysis. , 2004, The American journal of psychiatry.

[54]  J. Price,et al.  Glial reduction in amygdala in major depressive disorder is due to oligodendrocytes , 2004, Biological Psychiatry.

[55]  Peter Zwanzger,et al.  Reduced hippocampal volumes associated with the long variant of the serotonin transporter polymorphism in major depression. , 2004, Archives of general psychiatry.

[56]  Hiroki Toda,et al.  Inflammatory Blockade Restores Adult Hippocampal Neurogenesis , 2003, Science.

[57]  Ronald S Duman,et al.  Cell Proliferation in Adult Hippocampus is Decreased by Inescapable Stress: Reversal by Fluoxetine Treatment , 2003, Neuropsychopharmacology.

[58]  Paul J. Laurienti,et al.  An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets , 2003, NeuroImage.

[59]  P. Hof,et al.  Repeated restraint stress suppresses neurogenesis and induces biphasic PSA‐NCAM expression in the adult rat dentate gyrus , 2003, The European journal of neuroscience.

[60]  G. Kollias,et al.  Exclusive tumor necrosis factor (TNF) signaling by the p75TNF receptor triggers inflammatory ischemia in the CNS of transgenic mice , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[61]  G. JuanCéspedes,et al.  Tumor necrosis factor alpha genetic polymorphism as a risk factor in disease , 2002 .

[62]  Wolfgang Satzger,et al.  Liefern HAWIE-R, WST und MWT-B vergleichbare IQ-Werte? , 2002 .

[63]  S. Mohand-Said,et al.  Neurodegenerative and Neuroprotective Effects of Tumor Necrosis Factor (TNF) in Retinal Ischemia: Opposite Roles of TNF Receptor 1 and TNF Receptor 2 , 2002, The Journal of Neuroscience.

[64]  Wade Morishita,et al.  Control of Synaptic Strength by Glial TNFα , 2002, Science.

[65]  N. Tzourio-Mazoyer,et al.  Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject Brain , 2002, NeuroImage.

[66]  A. Paetau,et al.  Evolution of Cerebral Tumor Necrosis Factor-&agr; Production During Human Ischemic Stroke , 2001, Stroke.

[67]  Douglas K. Anderson,et al.  TNF‐α stimulates caspase‐3 activation and apoptotic cell death in primary septo‐hippocampal cultures , 2001, Journal of neuroscience research.

[68]  J. Szelényi Cytokines and the central nervous system , 2001, Brain Research Bulletin.

[69]  J. Bockaert,et al.  “Inflammatory” Cytokines , 2000, Journal of neurochemistry.

[70]  P. Patterson,et al.  Cytokine and Growth Factor Involvement in Long-Term Potentiation , 1999, Molecular and Cellular Neuroscience.

[71]  R. Allen Polymorphism of the human TNF-α promoter — random variation or functional diversity? , 1999 .

[72]  J. Price,et al.  Glial reduction in the subgenual prefrontal cortex in mood disorders. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[73]  W. Fiers,et al.  Cooperation of both TNF receptors in inducing apoptosis: involvement of the TNF receptor-associated factor binding domain of the TNF receptor 75. , 1998, Journal of immunology.

[74]  A. MacKenzie-Graham,et al.  Differential expression, cytokine modulation, and specific functions of type-1 and type-2 tumor necrosis factor receptors in rat glia , 1997, Journal of Neuroimmunology.

[75]  H. Mcdevitt,et al.  Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[76]  G. Kollias,et al.  Astrocyte-specific but not neuron-specific transmembrane TNF triggers inflammation and degeneration in the central nervous system of transgenic mice. , 1997, Journal of immunology.

[77]  G. Kollias,et al.  Neurobehavioral Alterations in Developing Transgenic Mice Expressing TNF-α in the Brain , 1996, Brain, Behavior, and Immunity.

[78]  Hong-Bing Shu,et al.  TRADD–TRAF2 and TRADD–FADD Interactions Define Two Distinct TNF Receptor 1 Signal Transduction Pathways , 1996, Cell.

[79]  J. J. O'Connor,et al.  Interleukin-1β (IL-1β) and tumour necrosis factor (TNF) inhibit long-term potentiation in the rat dentate gyrus in vitro , 1996, Neuroscience Letters.

[80]  F. Pociot,et al.  Functional Analysis of a New Polymorphism in the Human TNF α Gene Promoter , 1995, Scandinavian journal of immunology.

[81]  Jonathan D. Cohen,et al.  Improved Assessment of Significant Activation in Functional Magnetic Resonance Imaging (fMRI): Use of a Cluster‐Size Threshold , 1995, Magnetic resonance in medicine.

[82]  F. Eusebi,et al.  Tumor necrosis factor alters synaptic transmission in rat hippocampal slices , 1992, Neuroscience Letters.

[83]  C. Brosnan,et al.  Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. , 1991, The Journal of clinical investigation.

[84]  C. Blatteis Neuromodulative actions of cytokines. , 1990, The Yale journal of biology and medicine.

[85]  R A Bryant,et al.  Interactions between BDNF Val66Met polymorphism and early life stress predict brain and arousal pathways to syndromal depression and anxiety , 2009, Molecular Psychiatry.

[86]  R. Dantzer,et al.  From inflammation to sickness and depression: when the immune system subjugates the brain , 2008, Nature Reviews Neuroscience.

[87]  M. Pickering,et al.  Pro-inflammatory cytokines and their effects in the dentate gyrus. , 2007, Progress in brain research.

[88]  P. Moynagh,et al.  THE INHIBITORY EFFECT OF TUMOUR NECROSIS FACTOR-α ON LONG-TERM POTENTIATION IS ATTENUATED BY TYPE 1 METABOTROPIC GLUTAMATE RECEPTOR BLOCKADE , 2004 .

[89]  D. Dziewulska,et al.  Cellular expression of tumor necrosis factor a and its receptors in human ischemic stroke. , 2003, Clinical neuropathology.

[90]  Eric Vermetten,et al.  Circuits and systems in stress. I. Preclinical studies , 2002, Depression and anxiety.

[91]  R. Dantzer,et al.  Cytokine signals propagate through the brain , 2000, Molecular Psychiatry.

[92]  H. Wittchen,et al.  SKID I. Strukturiertes Klinisches Interview für DSM-IV. Achse I: Psychische Störungen. Interviewheft und Beurteilungsheft. Eine deutschsprachige, erweiterte Bearb. d. amerikanischen Originalversion des SKID I , 1997 .